SE0202608D0 - New sequences - Google Patents

New sequences

Info

Publication number
SE0202608D0
SE0202608D0 SE0202608A SE0202608A SE0202608D0 SE 0202608 D0 SE0202608 D0 SE 0202608D0 SE 0202608 A SE0202608 A SE 0202608A SE 0202608 A SE0202608 A SE 0202608A SE 0202608 D0 SE0202608 D0 SE 0202608D0
Authority
SE
Sweden
Prior art keywords
new sequences
agents
useful
ceta
pkc
Prior art date
Application number
SE0202608A
Other languages
English (en)
Inventor
Anneli Attersand
Staffan Lake
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Priority to SE0202608A priority Critical patent/SE0202608D0/sv
Publication of SE0202608D0 publication Critical patent/SE0202608D0/sv
Priority to PCT/SE2003/001361 priority patent/WO2004022592A1/en
Priority to AU2003256209A priority patent/AU2003256209A1/en

Links

SE0202608A 2002-09-04 2002-09-04 New sequences SE0202608D0 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE0202608A SE0202608D0 (sv) 2002-09-04 2002-09-04 New sequences
PCT/SE2003/001361 WO2004022592A1 (en) 2002-09-04 2003-09-03 Use of human protein kinase c-eta in methods for identification of pharmaceutically useful agents
AU2003256209A AU2003256209A1 (en) 2002-09-04 2003-09-03 Use of human protein kinase c-eta in methods for identification of pharmaceutically useful agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0202608A SE0202608D0 (sv) 2002-09-04 2002-09-04 New sequences

Publications (1)

Publication Number Publication Date
SE0202608D0 true SE0202608D0 (sv) 2002-09-04

Family

ID=20288884

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0202608A SE0202608D0 (sv) 2002-09-04 2002-09-04 New sequences

Country Status (3)

Country Link
AU (1) AU2003256209A1 (sv)
SE (1) SE0202608D0 (sv)
WO (1) WO2004022592A1 (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007089546A (ja) * 2005-09-30 2007-04-12 Univ Of Tokushima 関節リウマチ感受性遺伝子、及び関節リウマチ罹患リスクの測定方法
US20090324610A1 (en) 2006-04-25 2009-12-31 Kyushu Univeristy, National University Corporation Gene associated with arteriosclerotic disease, and use thereof
WO2018150430A1 (en) * 2017-02-19 2018-08-23 The National Institute for Biotechnology in the Negev Ltd. Peptide kinase inhibitors and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1490509A4 (en) * 2001-01-12 2005-06-01 Exelixis Inc MODULATION OF INSULIN RECEPTOR SIGNAL TRANSMISSION

Also Published As

Publication number Publication date
WO2004022592A1 (en) 2004-03-18
AU2003256209A1 (en) 2004-03-29

Similar Documents

Publication Publication Date Title
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
ATE451376T1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
DE60314603D1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
ATE466580T1 (de) Azolylaminoazine als proteinkinasehemmer
ATE468336T1 (de) Azolylaminoazine als proteinkinasehemmer
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
UA85559C2 (en) Aminobenzophenone compounds
BR0116452A (pt) Composto, composição farmacêutica, uso de um composto
DE602004021585D1 (de) 5,7-DIAMINOPYRAZOLOi4,3-D PYRIMIDINE ZUR VERWENDUNG IN DER BEHANDLUNG VON BLUTHOCHDRUCK
DE60314500D1 (de) Diaminopyrimidine und deren verwendung als angiogenesehemmer
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
DK1368060T3 (da) HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
ATE450530T1 (de) Zusammensetzungen zur verwendung als protein- kinase-inhibitoren
MXPA05013977A (es) Metodos y composiciones para tratar enfermedades relacionadas con amiloide.
BR0309665A (pt) Tratamento de deficiência de alfa-galactosidase a
HK1062923A1 (en) Igf-binding protein-derived peptide
NO20055741L (no) Nye kjemiske forbindelser
DE602004012578D1 (de) Als inhibitoren von c-met geeignete pyrrolzusammensetzungen
CY1110130T1 (el) Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α.
RS51138B (sr) S-mirtazapin za lečenje nastupa vreline (valunga)
SE0302304D0 (sv) Novel compounds
ATE522230T1 (de) Biphenyle als bilderzeugungsmittel bei der alzheimerschen krankheit
NO20060781L (no) Anvendelse av loselig CD164 ved inflammatoriske og/eller autoimmune lidelser
TR200200278T2 (tr) Kalsilitik bileşimler
SE0202608D0 (sv) New sequences